Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.
about
Ocular indicators of Alzheimer's: exploring disease in the retinaMagnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.Synthesis and biological evaluation of curcumin analogs as β-amyloid imaging agents.Biomarkers for the Early Detection and Progression of Alzheimer's Disease.Biomarkers in Neurodegenerative Diseases.Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies.
P2860
Imaging β-amyloid using [(18)F]flutemetamol positron emission tomography: from dosimetry to clinical diagnosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Imaging β-amyloid using [(18)F ...... simetry to clinical diagnosis.
@en
type
label
Imaging β-amyloid using [(18)F ...... simetry to clinical diagnosis.
@en
prefLabel
Imaging β-amyloid using [(18)F ...... simetry to clinical diagnosis.
@en
P2093
P2860
P1476
Imaging β-amyloid using [(18)F ...... simetry to clinical diagnosis.
@en
P2093
Antoine Leuzy
Eduardo R Zimmer
Kerstin Heurling
Mark Lubberink
P2860
P2888
P304
P356
10.1007/S00259-015-3208-1
P577
2015-10-06T00:00:00Z